Sean Carney, Former Managing Director of Warburg Pincus.
During 2017, Sean worked with Hillhouse Capital, a leading investment firm in Asia with over $30 billion in assets under management across hedge fund, private equity, and credit activities. Sean worked with Hillhouse to develop a US private equity strategy, and in the process completed several investments, including two healthcare investments: Carestream Dental (global dental equipment and practice management software), and Vets First Choice (global pharmaceutical management services for veterinary practices).
Sean was previously an investment professional for approximately twenty years with Warburg Pincus, a leading global private equity firm with over $40 billion of assets under management. Sean was active across a range of industries (with a particular focus on healthcare, especially medical devices), geographies (including three years based in London and significant activity in Asia), stages of development, and transaction types. Notable investments in medical devices include Bausch + Lomb (sold to Valeant for $8.7 billion), DexCom (NASDAQ: DXCM), ev3 (sold to Covidien for over $2 billion), MicroTherapeutics, Tornier (NASDAQ: TRNX), Velocimed (sold to St. Jude Medical), and Wright Medical (NASDAQ: WMGI). Sean has been a board member for over twenty companies, including five public companies.
Prior to joining Warburg Pincus, Sean worked at McKinsey for three years and at Goldman Sachs. Sean received an MBA from Harvard Business School in 1995 and an AB in Economics (magna cum laude with Phi Beta Kappa honors) from Harvard College in 1991.
Les Cross, Former CEO of DJO Global, Inc. and Alphatec Spine, Inc.
Mr. Cross previously served as the Chairman and Chief Executive Officer of Alphatec Spine from February 2012 to April 2014 and served as the Chairman and interim Chief Executive Officer from September 2016 to December 2016.
Mr. Cross is the former President and Chief Executive Officer of DJO Global, Inc. Mr. Cross served as a Director of DJO Global until December 2012. DJO Global is a manufacturer and worldwide leading distributor of electrotherapy products for pain therapy and rehabilitation, clinical devices for the treatment of patients in physical therapy clinics, knee, hip and shoulder implant products, and orthopedic rehabilitation products, including rigid knee bracing, orthopedic soft goods, cold therapy systems, vascular systems and bone growth stimulation devices. Mr. Cross has held principal executive roles at DJO Global and its predecessors since 1995.
From 1990 to 1994, Mr. Cross held the position of Senior Vice President of Marketing and Business Development of the Bracing & Support Systems division of Smith & Nephew. He was a Managing Director of two different divisions of Smith & Nephew from 1982 to 1990.
Jess H. Lonner, M.D., Rothman Institute
Dr. Lonner is a board certified orthopedic surgeon who specializes in the treatment of arthritis of the knee, as well as arthroscopic treatments for meniscus tears. He is an internationally recognized leader in minimally invasive partial and total knee replacement surgery, with a unique focus in robotic-assisted techniques. Patients from around the world have sought his care and countless surgeons have learned from him.
He received his undergraduate degree from Boston University and attended Boston University School of Medicine. Dr. Lonner completed his residency at the Hospital for Joint Diseases in New York, NY and his Fellowship in Knee Arthroplasty Reconstruction at Massachusetts General Hospital/Harvard Medical School and New England Baptist Hospital in Boston, MA.
Paul K. Nichols Jr., President & CEO, Bio2 Technologies, Inc
Mr. Nichols has 38 years of experience with rapidly growing companies in the medical device industry, with the past 30 years as an executive and entrepreneur in the musculoskeletal sector.
Between 1995 and 2005 he was a founder and CEO of three orthopedic surgery technology companies with successful exits, the most recent being Nexa Orthopedics which was acquired by Tornier (NASD:TRNX) in 2007.
Eric Timko, Chairman and CEO, OrthAlign, Inc.
Mr. Timko currently serves as the Chairman and CEO of OrthAlign, Inc. Previously, he served as President and CEO of Blue Belt Technologies. Mr. Timko joined Blue Belt Technologies in August 2011, bringing with him over 20 years of experience in the medical device industry. He led Blue Belt Technologies through the transition from a developmental stage company to a commercially driven company. Over the first full year of commercialization, Blue Belt Technologies achieved over $10 million in revenue. In 2016, Blue Belt Technologies was acquired by Smith and Nephew for $275 million.
Prior to joining Blue Belt Technologies, Mr. Timko led both start-up and commercial stage companies in various medical specialties. He served as President and CEO of NeuroVasx, Inc., President of Carl Zeiss Surgical, Inc., and Vice President of Siemens Medical Systems, Inc.
Mr. Timko serves on the Boards of Directors of XTANT Medical, OrthAlign, iota Motion and the Minnesota Chapter of Folds of Honor.
Mr. Timko received a BA from Kent State University.